ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GFAP Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-33I8531
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GFAP Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global GFAP Antibody Market Research Report 2025

Code: QYRE-Auto-33I8531
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aviva Systems Biology
Merck
FineTest
Santa Cruz Biotechnology
Miltenyi Biotec
Sino Biological
Enzo Life Sciences
Proteintech
Atlas Antibodies
GeneTex
Synaptic Systems
Hytest
ProSci
EnCor Biotechnology

GFAP Antibody Market

The global market for GFAP Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for GFAP Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GFAP Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for GFAP Antibody in Immunofluorescence is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of GFAP Antibody include Aviva Systems Biology, Merck, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Sino Biological, Enzo Life Sciences, Proteintech, Atlas Antibodies, GeneTex, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GFAP Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GFAP Antibody.
The GFAP Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GFAP Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GFAP Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of GFAP Antibody Market Report

Report Metric Details
Report Name GFAP Antibody Market
Segment by Type
  • Polyclonal
  • Monoclonal
Segment by Application
  • Immunofluorescence
  • Western Blot
  • Immunohistochemistry Frozen
  • Immunohistochemistry Paraffin
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aviva Systems Biology, Merck, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Sino Biological, Enzo Life Sciences, Proteintech, Atlas Antibodies, GeneTex, Synaptic Systems, Hytest, ProSci, EnCor Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of GFAP Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GFAP Antibody Market report?

Ans: The main players in the GFAP Antibody Market are Aviva Systems Biology, Merck, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Sino Biological, Enzo Life Sciences, Proteintech, Atlas Antibodies, GeneTex, Synaptic Systems, Hytest, ProSci, EnCor Biotechnology

What are the Application segmentation covered in the GFAP Antibody Market report?

Ans: The Applications covered in the GFAP Antibody Market report are Immunofluorescence, Western Blot, Immunohistochemistry Frozen, Immunohistochemistry Paraffin, Others

What are the Type segmentation covered in the GFAP Antibody Market report?

Ans: The Types covered in the GFAP Antibody Market report are Polyclonal, Monoclonal

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GFAP Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global GFAP Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunofluorescence
1.3.3 Western Blot
1.3.4 Immunohistochemistry Frozen
1.3.5 Immunohistochemistry Paraffin
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GFAP Antibody Market Perspective (2020-2031)
2.2 Global GFAP Antibody Growth Trends by Region
2.2.1 Global GFAP Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 GFAP Antibody Historic Market Size by Region (2020-2025)
2.2.3 GFAP Antibody Forecasted Market Size by Region (2026-2031)
2.3 GFAP Antibody Market Dynamics
2.3.1 GFAP Antibody Industry Trends
2.3.2 GFAP Antibody Market Drivers
2.3.3 GFAP Antibody Market Challenges
2.3.4 GFAP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GFAP Antibody Players by Revenue
3.1.1 Global Top GFAP Antibody Players by Revenue (2020-2025)
3.1.2 Global GFAP Antibody Revenue Market Share by Players (2020-2025)
3.2 Global GFAP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by GFAP Antibody Revenue
3.4 Global GFAP Antibody Market Concentration Ratio
3.4.1 Global GFAP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GFAP Antibody Revenue in 2024
3.5 Global Key Players of GFAP Antibody Head office and Area Served
3.6 Global Key Players of GFAP Antibody, Product and Application
3.7 Global Key Players of GFAP Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GFAP Antibody Breakdown Data by Type
4.1 Global GFAP Antibody Historic Market Size by Type (2020-2025)
4.2 Global GFAP Antibody Forecasted Market Size by Type (2026-2031)
5 GFAP Antibody Breakdown Data by Application
5.1 Global GFAP Antibody Historic Market Size by Application (2020-2025)
5.2 Global GFAP Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America GFAP Antibody Market Size (2020-2031)
6.2 North America GFAP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America GFAP Antibody Market Size by Country (2020-2025)
6.4 North America GFAP Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GFAP Antibody Market Size (2020-2031)
7.2 Europe GFAP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe GFAP Antibody Market Size by Country (2020-2025)
7.4 Europe GFAP Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GFAP Antibody Market Size (2020-2031)
8.2 Asia-Pacific GFAP Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific GFAP Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific GFAP Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GFAP Antibody Market Size (2020-2031)
9.2 Latin America GFAP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America GFAP Antibody Market Size by Country (2020-2025)
9.4 Latin America GFAP Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GFAP Antibody Market Size (2020-2031)
10.2 Middle East & Africa GFAP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa GFAP Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa GFAP Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aviva Systems Biology
11.1.1 Aviva Systems Biology Company Details
11.1.2 Aviva Systems Biology Business Overview
11.1.3 Aviva Systems Biology GFAP Antibody Introduction
11.1.4 Aviva Systems Biology Revenue in GFAP Antibody Business (2020-2025)
11.1.5 Aviva Systems Biology Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck GFAP Antibody Introduction
11.2.4 Merck Revenue in GFAP Antibody Business (2020-2025)
11.2.5 Merck Recent Development
11.3 FineTest
11.3.1 FineTest Company Details
11.3.2 FineTest Business Overview
11.3.3 FineTest GFAP Antibody Introduction
11.3.4 FineTest Revenue in GFAP Antibody Business (2020-2025)
11.3.5 FineTest Recent Development
11.4 Santa Cruz Biotechnology
11.4.1 Santa Cruz Biotechnology Company Details
11.4.2 Santa Cruz Biotechnology Business Overview
11.4.3 Santa Cruz Biotechnology GFAP Antibody Introduction
11.4.4 Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2020-2025)
11.4.5 Santa Cruz Biotechnology Recent Development
11.5 Miltenyi Biotec
11.5.1 Miltenyi Biotec Company Details
11.5.2 Miltenyi Biotec Business Overview
11.5.3 Miltenyi Biotec GFAP Antibody Introduction
11.5.4 Miltenyi Biotec Revenue in GFAP Antibody Business (2020-2025)
11.5.5 Miltenyi Biotec Recent Development
11.6 Sino Biological
11.6.1 Sino Biological Company Details
11.6.2 Sino Biological Business Overview
11.6.3 Sino Biological GFAP Antibody Introduction
11.6.4 Sino Biological Revenue in GFAP Antibody Business (2020-2025)
11.6.5 Sino Biological Recent Development
11.7 Enzo Life Sciences
11.7.1 Enzo Life Sciences Company Details
11.7.2 Enzo Life Sciences Business Overview
11.7.3 Enzo Life Sciences GFAP Antibody Introduction
11.7.4 Enzo Life Sciences Revenue in GFAP Antibody Business (2020-2025)
11.7.5 Enzo Life Sciences Recent Development
11.8 Proteintech
11.8.1 Proteintech Company Details
11.8.2 Proteintech Business Overview
11.8.3 Proteintech GFAP Antibody Introduction
11.8.4 Proteintech Revenue in GFAP Antibody Business (2020-2025)
11.8.5 Proteintech Recent Development
11.9 Atlas Antibodies
11.9.1 Atlas Antibodies Company Details
11.9.2 Atlas Antibodies Business Overview
11.9.3 Atlas Antibodies GFAP Antibody Introduction
11.9.4 Atlas Antibodies Revenue in GFAP Antibody Business (2020-2025)
11.9.5 Atlas Antibodies Recent Development
11.10 GeneTex
11.10.1 GeneTex Company Details
11.10.2 GeneTex Business Overview
11.10.3 GeneTex GFAP Antibody Introduction
11.10.4 GeneTex Revenue in GFAP Antibody Business (2020-2025)
11.10.5 GeneTex Recent Development
11.11 Synaptic Systems
11.11.1 Synaptic Systems Company Details
11.11.2 Synaptic Systems Business Overview
11.11.3 Synaptic Systems GFAP Antibody Introduction
11.11.4 Synaptic Systems Revenue in GFAP Antibody Business (2020-2025)
11.11.5 Synaptic Systems Recent Development
11.12 Hytest
11.12.1 Hytest Company Details
11.12.2 Hytest Business Overview
11.12.3 Hytest GFAP Antibody Introduction
11.12.4 Hytest Revenue in GFAP Antibody Business (2020-2025)
11.12.5 Hytest Recent Development
11.13 ProSci
11.13.1 ProSci Company Details
11.13.2 ProSci Business Overview
11.13.3 ProSci GFAP Antibody Introduction
11.13.4 ProSci Revenue in GFAP Antibody Business (2020-2025)
11.13.5 ProSci Recent Development
11.14 EnCor Biotechnology
11.14.1 EnCor Biotechnology Company Details
11.14.2 EnCor Biotechnology Business Overview
11.14.3 EnCor Biotechnology GFAP Antibody Introduction
11.14.4 EnCor Biotechnology Revenue in GFAP Antibody Business (2020-2025)
11.14.5 EnCor Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Aviva Systems Biology
Merck
FineTest
Santa Cruz Biotechnology
Miltenyi Biotec
Sino Biological
Enzo Life Sciences
Proteintech
Atlas Antibodies
GeneTex
Synaptic Systems
Hytest
ProSci
EnCor Biotechnology
List of Tables
 Table 1. Global GFAP Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polyclonal
 Table 3. Key Players of Monoclonal
 Table 4. Global GFAP Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global GFAP Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global GFAP Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global GFAP Antibody Market Share by Region (2020-2025)
 Table 8. Global GFAP Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global GFAP Antibody Market Share by Region (2026-2031)
 Table 10. GFAP Antibody Market Trends
 Table 11. GFAP Antibody Market Drivers
 Table 12. GFAP Antibody Market Challenges
 Table 13. GFAP Antibody Market Restraints
 Table 14. Global GFAP Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global GFAP Antibody Market Share by Players (2020-2025)
 Table 16. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2024)
 Table 17. Ranking of Global Top GFAP Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by GFAP Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of GFAP Antibody, Headquarters and Area Served
 Table 20. Global Key Players of GFAP Antibody, Product and Application
 Table 21. Global Key Players of GFAP Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global GFAP Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global GFAP Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global GFAP Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global GFAP Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global GFAP Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global GFAP Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global GFAP Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global GFAP Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America GFAP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America GFAP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe GFAP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe GFAP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific GFAP Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific GFAP Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific GFAP Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America GFAP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America GFAP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa GFAP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa GFAP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Aviva Systems Biology Company Details
 Table 47. Aviva Systems Biology Business Overview
 Table 48. Aviva Systems Biology GFAP Antibody Product
 Table 49. Aviva Systems Biology Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 50. Aviva Systems Biology Recent Development
 Table 51. Merck Company Details
 Table 52. Merck Business Overview
 Table 53. Merck GFAP Antibody Product
 Table 54. Merck Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 55. Merck Recent Development
 Table 56. FineTest Company Details
 Table 57. FineTest Business Overview
 Table 58. FineTest GFAP Antibody Product
 Table 59. FineTest Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 60. FineTest Recent Development
 Table 61. Santa Cruz Biotechnology Company Details
 Table 62. Santa Cruz Biotechnology Business Overview
 Table 63. Santa Cruz Biotechnology GFAP Antibody Product
 Table 64. Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 65. Santa Cruz Biotechnology Recent Development
 Table 66. Miltenyi Biotec Company Details
 Table 67. Miltenyi Biotec Business Overview
 Table 68. Miltenyi Biotec GFAP Antibody Product
 Table 69. Miltenyi Biotec Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 70. Miltenyi Biotec Recent Development
 Table 71. Sino Biological Company Details
 Table 72. Sino Biological Business Overview
 Table 73. Sino Biological GFAP Antibody Product
 Table 74. Sino Biological Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 75. Sino Biological Recent Development
 Table 76. Enzo Life Sciences Company Details
 Table 77. Enzo Life Sciences Business Overview
 Table 78. Enzo Life Sciences GFAP Antibody Product
 Table 79. Enzo Life Sciences Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 80. Enzo Life Sciences Recent Development
 Table 81. Proteintech Company Details
 Table 82. Proteintech Business Overview
 Table 83. Proteintech GFAP Antibody Product
 Table 84. Proteintech Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 85. Proteintech Recent Development
 Table 86. Atlas Antibodies Company Details
 Table 87. Atlas Antibodies Business Overview
 Table 88. Atlas Antibodies GFAP Antibody Product
 Table 89. Atlas Antibodies Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 90. Atlas Antibodies Recent Development
 Table 91. GeneTex Company Details
 Table 92. GeneTex Business Overview
 Table 93. GeneTex GFAP Antibody Product
 Table 94. GeneTex Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 95. GeneTex Recent Development
 Table 96. Synaptic Systems Company Details
 Table 97. Synaptic Systems Business Overview
 Table 98. Synaptic Systems GFAP Antibody Product
 Table 99. Synaptic Systems Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 100. Synaptic Systems Recent Development
 Table 101. Hytest Company Details
 Table 102. Hytest Business Overview
 Table 103. Hytest GFAP Antibody Product
 Table 104. Hytest Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 105. Hytest Recent Development
 Table 106. ProSci Company Details
 Table 107. ProSci Business Overview
 Table 108. ProSci GFAP Antibody Product
 Table 109. ProSci Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 110. ProSci Recent Development
 Table 111. EnCor Biotechnology Company Details
 Table 112. EnCor Biotechnology Business Overview
 Table 113. EnCor Biotechnology GFAP Antibody Product
 Table 114. EnCor Biotechnology Revenue in GFAP Antibody Business (2020-2025) & (US$ Million)
 Table 115. EnCor Biotechnology Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. GFAP Antibody Picture
 Figure 2. Global GFAP Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GFAP Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Polyclonal Features
 Figure 5. Monoclonal Features
 Figure 6. Global GFAP Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global GFAP Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Immunofluorescence Case Studies
 Figure 9. Western Blot Case Studies
 Figure 10. Immunohistochemistry Frozen Case Studies
 Figure 11. Immunohistochemistry Paraffin Case Studies
 Figure 12. Others Case Studies
 Figure 13. GFAP Antibody Report Years Considered
 Figure 14. Global GFAP Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global GFAP Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global GFAP Antibody Market Share by Region: 2024 VS 2031
 Figure 17. Global GFAP Antibody Market Share by Players in 2024
 Figure 18. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by GFAP Antibody Revenue in 2024
 Figure 20. North America GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America GFAP Antibody Market Share by Country (2020-2031)
 Figure 22. United States GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe GFAP Antibody Market Share by Country (2020-2031)
 Figure 26. Germany GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific GFAP Antibody Market Share by Region (2020-2031)
 Figure 34. China GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America GFAP Antibody Market Share by Country (2020-2031)
 Figure 42. Mexico GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa GFAP Antibody Market Share by Country (2020-2031)
 Figure 46. Turkey GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE GFAP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Aviva Systems Biology Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 50. Merck Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 51. FineTest Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 52. Santa Cruz Biotechnology Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 53. Miltenyi Biotec Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 54. Sino Biological Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 55. Enzo Life Sciences Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 56. Proteintech Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 57. Atlas Antibodies Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 58. GeneTex Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 59. Synaptic Systems Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 60. Hytest Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 61. ProSci Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 62. EnCor Biotechnology Revenue Growth Rate in GFAP Antibody Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Antibodies Market Research Report 2024
Global CAPG Antibody Market Research Report 2024
Global Antibody Testing Market Research Report 2024
Global BCAM Antibody Market Research Report 2024
Global Primary Antibody Market Research Report 2024
Global FOX2 Antibody Market Research Report 2024
Global Albumin Antibody Market Research Report 2024
Global PARP1 Antibody Market Research Report 2024
Global Adiponectin Antibody Market Research Report 2024
Global Akt Antibody Market Research Report 2024
Global Ready to Use Antibodies Market Research Report 2025
Global Osteocalcin Antibody Market Research Report 2024
Global Research Antibodies Market Research Report 2025
Global Epitope Tag Antibody Market Research Report 2024
Global PECAM 1 Antibody Market Research Report 2024
Global Antibody Array Market Research Report 2025
Global Escherichia Coli Antibody Market Research Report 2024
Global EGFR Antibody Market Research Report 2024
Global Anti Osteocalcin Antibody Market Research Report 2024
Global Antibody Chips Market Research Report 2025

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions